Date post: | 11-Aug-2015 |
Category: |
Health & Medicine |
Upload: | ilsintelligence |
View: | 260 times |
Download: | 0 times |
Introduction to ilSBES 2014
March 10th - 12th, 2014
ilS enables the access to life sciences experts carefully selected through the ilS NetworkSM
DecisionMakers
Physicians
Researchers
• Payers (Governments& Insurances)
• Regulatory Agencies• Hospital Managers
• Ophthalmology• Neurology/Pain• Respiratory• Gastrointestinal• Rheumat./Autoimm.• Oncology• Dermatology…
• Basic Research• In vitro assessment• Translational Research• In vivo assessment• Genomics, proteomics…
2
ilS NetworkSM
3
The ilS NetworkSM covers the top 5 EU countries, USA, and the “pharmerging” countries (Mexico, China,…)
Based on the client needs, wealso focus on additional
geographies and / or knowledgeareas on an ad hoc basis
LEGEND: Researchers; Physicians: Decision Makers
The diagram shows how ilS works with its clients (Pharma, Biotech or Medical Device Companies)
*ilS SolutionsSM: ilS ConnectionsSM
ilS InterviewsSM
ilS SurveysSM
ilS KnowledgeSM
Experts selected are
shared with the
Client Company
CLIENT
(Pharmaceutical Company,
Biotech, Medical Device,
VC, CRO,...)
LEGEND:
Researchers:
Physicians:
Decision Makers:
ilS screens the best
profiles based on
Client needs
ilS
NetworkSM
ilS NetworkSM experts
wish
to share their
knowkedge
* ilS professionals help the clients
framing the research topic, custom recruit the experts, recommend the
best consulting method and perform the consultations
ilS InterviewsSM
ilS SurveysSM
ilS ConnectionSM
ilS KnowledgeSM
Market intelligence:BenchmarkingCompetitive
intelligenceOpportunity
assessmentSWOT & PEST
Market Access:Value DossiersHealth EconomicsP&R Negotiation tools
ilS InsightsSM
5
ilS Primary Research Solutions complement Market Research and Market Access Solutions (ilS InsightsSM)
Market Research &
Competitive Intelligence:
• Benchmarking
• Opportunity
assessment
• Partner identification
Market Access &
Government Affairs:
• Stakeholder mapping
• Value Dossier
• CEA and BIM
• Price & MA Strategy
ilS InsightsSM
Primary Research Solutions
6
**********
Before being able to participate in a project, experts must satisfactorily answer the screening questions
Case Studies
I. Pharma Company trying to gain insights in regards to the potential pipeline inclusion of the Fragile X Syndrome condition
Business Development: Should I incorporate the FXS into my Company’s pipeline?
CLIENT CHALLENGE
• Perform Opportunity Assessment (ilS InsightsSM) in order to understand market size and current competitors
• Gain insights from KOLs – top USA researchers(ilS InterviewsSM)• Researcher from the Department of
Biological Chemistry and Molecular Pharmacology, Harvard Medical School
• Head of the Laboratory of Molecular Neuro-oncology, Rockefeller University and FRAXA Research Foundation Scientific Advisor
ilS SOLUTION
II. Chilean Biopharma Company willing to license a newly developed RSV vaccine
C-Suite: Which Companies might be interested on in-licensing my vaccine, and how much are they willing to pay?
CLIENT CHALLENGE
• Perform benchmark assessment (ilS InsightsSM) in order to identify potential licensees (EU and USA)
• Hold interviews with paediatricians in order to understand real market need (ilS InterviewsSM):• Neonatologist, Advisor of the Chilean Health
Vaccines and Immunization StrategiesCommittee
• Paediatrician-in-chief at the Hospital NacionalProf. Dr. Juan P. Garrahan, Argentina
• Paediatricians from top hospitals of China, France, Germany, India, Italy and Spain were also interviewed
ilS SOLUTION
III. Pharma Company trying to gain anunderstanding of its brand perception in comparison to four other Companies
Marketing: Do decision makers like our brand? Are werendering enough Hospital visits?
CLIENT CHALLENGE
• ilS developed an online Survey (ilS SurveySM) and sent it to 50 hospital managers and 50 pharmacymanagers from top Spanish Hospitals:• Hospital Managers: Hospital Gregorio Marañón,
Hospital de Santiago, Hospital Virgen del Rocío, Hospital 12 de Octubre, Hospital de Bellvitge…
• Pharmacy Managers: Hospital Politécnico La Fe, Hospital Vall d'Hebrón, Hospital de Donostia, Hospital Virgen de las Nieves, Hospital La Paz…
• ilS performed a quantitative analysis of the resultsand shared insights with the client
ilS SOLUTION
LEGEND: Researchers Physicians Decision Makers
IV. Pharma Company trying to start a P&R procedure in Spain for a new product indication
Market Access: Which are my product barriers? Will my value proposition overcome them?
CLIENT CHALLENGE
• Conduct a product perception (ilSInterviewsSM)study with 10 KOLs and 10 payers• Private Ophthalmologists, Vocal of Spanish
Society of Ophthalmology• Ophthalmologists: Hospital Ramon y Cajal,
Hospital Vall d’Hebron…• Pharmacists: Hospital Ramon y Cajal,
Hospital Vall d’Hebron…• Prepare an Objection Handler along with the
product Value Dossier (ilS InsightsSM), tailored tophysicians and payers
ilS SOLUTION
LEGEND: Researchers Physicians Decision Makers
V. Pharma Company trying to understandPrice Sensitivity for a innovative productready to be launched
Market Access: Will decision makers include my product in their hospital portfolio? How much willthey pay for my product?
CLIENT CHALLENGE
• ilS put together two Advisory boards of decision makers- Hospital Managers and Pharmacy Managers from top Italian Hospitals:• Hospital Managers: Ospedale Niguarda,
Ospedale Maggiore Policlinico, Ospedale San Paolo, Ospedale Luiggi Sacco...
• Pharmacy Managers: Ospedale San Camillo, Ospedale Fatebenefratelli, Ospedale San Giovanni Addolorata…
• ilS developed the Advisory board discussion guide, moderated the session and shared insights withthe client (ilS KnowledgeSM)
ilS SOLUTION
LEGEND: Researchers Physicians Decision Makers
Why ilS?
ilS brings the knowledge companies need to achieve their commercial excellence…
SECTOR
KNOWLEDGE
GLOBAL
FIRM
EXPERIENCE
PROVEN
METHODOLOGIES
EXCELLENCE
► ilS is an independent company truly dedicated to the Pharma, Biotech and Medical Devicessectors► We have a unique access to global and local key stakeholders to gain first hand information
► ilS counts with a senior team with broad managing and consulting experience in thePharma, Biotech and Medical Devices sectors
► A methodology to conduct primary research that ensures the highest quality standards► The most timely, rapid and efficient primary research for Pharma, Biotech and MedicalDevices companies today in the market
► ilS motto is to provide its clients with the highest quality standards► We are focused on supporting the client throughout all the phases of the project, ensuringour ambitious quality standards are met
► ilS networkSM counts with Life Sciences experts (healthcare providers, decision makers,industry representatives,…) from all over the world► ilS is a strong company headquartered in Barcelona, Spain, and with a global presence
14
ilS team has worked for top Organizations from allover the world
15
Backup
17
Before joining the ilS NetworkSM, the experts mustmeet a set of requirements as shown below
BibiliometricAssessment
Influence LevelDegree of Expertise
Status
Articles Patents Citations Congress # Years Cl. Trials Position Relations
PHYSICIANS
DECISION MAKERS
RESEARCHERS
Profile Type:
Expert Rising Star Key Opinion Leader
18
Before joining the ilS NetworkSM, the experts must signa T&C agreement…
INDEX OF CONTENTS:
1. Services: Dealing with Conflicts of Interest Quality of Service
2. Obligations: Accuracy of information and data Regulatory Compliance Confidentiality
3. Compensation4. Liability5. Confidentiality Agreement6. Intellectual Property7. Contract Breach
Annex 1: Quality of ServicesAnnex 2: Description of ServicesAnnex 3: Dispute Resolution
To ensure a smooth, fast process, from project start to finish, ilS offers a set of value added solutions:
ilS SurveysSM
ilS InterviewsSM
Project Guidance
Expert Screening
Phone interview
Transcript/
Qualitative Report
Project Guidance
Expert Screening
Online survey
Data analysis
Quantitative
Report
ilS KnowledgeSM
Ad hoc Solutions:
• Expert Panels
• Reports /
Articles
• Lectures /
Conferences /
ilS InsightsSM
Competitive
Intelligence:
• Benchmarking
• Opportunity
assessment
• Partner
identification
Market Access:
• Stakeholder
mapping
• Value Dossier
• CEA and BIM
• Price & MA
Strategy
ilS ConnectionSM
Project
Guidance
Expert
Screening
Telephone call
scheduling
ilS brings the knowledge companies need to achieve their commercial excellence
All Rights Reserved